American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

Warning to Consumers

FDA Analysis Finds Toxins, Carcinogens in Electronic Cigarettes

By David Mitchell

The idea that electronic cigarettes offer tobacco users a safer alternative than, say, a pack of Marlboros recently seems to have gone up in smoke.
FDA handout warning of e-cigarette hazards
The FDA issued a warning about the so-called e-cigarettes on July 22, advising consumers about health risks associated with the products, which are battery-operated devices designed to look like and be used in the same manner as regular cigarettes. The devices turn nicotine and other chemicals into a vapor that is inhaled by the user. Manufacturers have touted the smokeless products as safer than conventional cigarettes.

However, after analyzing samples of e-cigarettes and components from two leading brands, the Division of Pharmaceutical Analysis in the FDA's Center for Drug Evaluation and Research said the samples showed detectable levels of known carcinogens and toxic chemicals.

The FDA raised a number of specific issues with the products.
  • Tobacco-specific nitrosamines, which are carcinogens, were detected in half of the samples tested.
  • The tobacco-specific impurities anabasine, myosmine and beta-nicotyrine were detected in a majority of the samples.
  • The vast majority of cartridges labeled as containing no nicotine did, in fact, contain low levels of nicotine.
  • On testing three different cartridges with the same label, each cartridge emitted a different amount of nicotine.
Furthermore, FDA officials said the test results "suggested that quality-control processes used to manufacture these products are inconsistent or nonexistent." For example, diethylene glycol, a toxic ingredient used in antifreeze, was detected in one cartridge.

"Electronic cigarettes are made overseas, mainly in China, and have not previously been tested for safety," said FP Tom Houston, M.D., of Dublin, Ohio. Houston is director of OhioHealth's Nicotine Dependence Program and clinical professor in the family medicine department at Ohio State University, Columbus.

"As we now see, they may contain more than just nicotine and flavorings," said Houston of the FDA's announcement. "It is also a concern that their novelty, the attractive flavoring, and marketing through the Internet may attract youth to the products."

E-cigarettes are sold without legal age restrictions and do not contain health warnings comparable to those found on FDA-approved nicotine replacement products or conventional cigarettes.

Houston, who is chairman of the AAFP Tobacco Cessation Advisory Committee, said electronic cigarettes aren't a safe substitute for conventional cigarettes and should not be used as a smoking cessation aid. He said people who want to stop smoking have proven methods available to them, such as
  • seeking help from their family physician or other health care professional;
  • pursuing tobacco cessation counseling through telephone Quitline services ([800] QUIT-NOW) or programs offered at many hospitals, health departments and voluntary health agencies;
  • via Internet-based services such as QuitNet; and
  • using FDA-approved medications known to increase the effectiveness of attempts to quit.

Share this on AAFP Connection

Health of the Public

Study: PPI Does Not Routinely Improve Asthma Control

Recalled Oral Contraceptives Pose Pregnancy Risk

CDC to Fund 2D Vaccine Barcoding Pilot

2012 Immunization Schedules Reflect Multiple Changes

Study: Cognitive Decline Detected in Middle-aged Adults

CDC Toolkit Can Help Clinicians Fight Norovirus Infection

Patient-Centered Care Linked to Lower Mortality

Study: Inappropriate Cancer Screenings Continue

Novartis Manufacturing Plant Closes After Drug Mix-ups

FDA Announces Classwide REMS for TIRF Medications

New Infants' Acetaminophen Products Hit Store Shelves

Avoid Environmental Factors Linked to Breast Cancer

Risk for Thrombosis Prompts REMS for Rivaroxaban

Common Drugs Implicated in Most Emergency Hospitalizations

CDC Launches Campaign for Child Medication Safety

HHS Blocks Expanded OTC Access to Plan B

Push Is On to Vaccinate Pregnant, Postpartum Women

FDA Committee Votes to Broaden PCV13 Indication

AAFP Foundation Program Aims to Fight Chronic Disease

NIAAA Alcohol Screening Guide Targets Teens

Walgreens, AAFP Launch Flu Vaccine Pilot in Five States

Helping Patients Quit Smoking Starts With a Question

Trilipix Efficacy in Question, Says FDA

USPSTF Addresses Skin Cancer, Obesity, Cervical Cancer Screening

AAFP Endorses ACP Guideline on ED

ACIP Recommends Expanded HPV, Hepatitis B Vaccination

Bacterial Contamination Spurs Nasal Spray Recall

CDC Renews Call for PCV13 Vaccination

USPSTF Recommends Against PSA Screening

AAFP Supports HHS' Million Hearts Initiative

FDA Phases Out Primatene Mist Inhalers

AHRQ Guides Explain Benefits, Risks of GERD Treatments

Tar Wars Winner Gives Back

Office Champions Project Nets Smoking Cessation Gains

Multiple Lots of Oral Contraceptives Recalled

New Vaccine Review Finds Few Adverse Events

HPV Vaccination Rates Still Lag, Says CDC

Renal Injury Prompts Reclast Label Changes

High-dose Citalopram Linked to Abnormal Heart Rhythms

AHRQ Sleep Apnea Guides Review Diagnosis, Management

Board Chair Spotlights Breadth of Family Medicine Training

USPSTF Softens Stance on Bladder Cancer Screening

HHS Expands Coverage for Women's Preventive Services

Teledermatology Project Aids Underserved Patients

New Chantix Warnings Cite Cardiovascular Risk

Pertussis Outbreaks Lead to CDC Alert on PCR Testing